Investor Relations & Capital Introduction in Durham

Durham holds the research and clinical centre of the Research Triangle, anchored by a major university and medical system. For founders in therapeutics, diagnostics and medical technology, it is among the most scientifically informed markets in the southeastern United States.

Why Durham Matters for Capital Raising

The university and its health system generate a continuous flow of research and clinical trial activity, and the investor community around it conducts diligence with genuine domain knowledge.

Contract research and pharmaceutical services businesses are heavily represented in the region, which means founders can often find both investors and operational partners in the same market.

Costs sit well below Boston or the Bay Area, and allocators expect that to be reflected in capital plans.

What Durham Investors Examine

Clinical and regulatory pathway are examined in detail, with attention to trial design.

Academic and clinical relationships carry weight where technology originated in institutional research.

Engagement and Access

GCN connects founders with Durham venture investors, family offices and institutional allocators through conference programming and private sessions across the Research Triangle.

Sectors where we see consistent interest include therapeutics, diagnostics, medical devices, pharmaceutical services and health technology.

Partner with Global Capital Network

Whether you are raising into Durham or allocating from it, our team can discuss how our investor relations infrastructure applies to your objectives.